These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 16394378)

  • 1. Cutaneous reactions in nuclear, biological and chemical warfare.
    Arora S
    Indian J Dermatol Venereol Leprol; 2005; 71(2):80-6. PubMed ID: 16394378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological and chemical terrorism: recognition and management.
    Noeller TP
    Cleve Clin J Med; 2001 Dec; 68(12):1001-2, 1004-9, 1013-6. PubMed ID: 11765118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous manifestations of category A bioweapons.
    Aquino LL; Wu JJ
    J Am Acad Dermatol; 2011 Dec; 65(6):1213.e1-1213.e15. PubMed ID: 21777993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous manifestations of biological warfare and related threat agents.
    McGovern TW; Christopher GW; Eitzen EM
    Arch Dermatol; 1999 Mar; 135(3):311-22. PubMed ID: 10086453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacy preparedness for incidents involving weapons of mass destruction.
    Burda AM; Sigg T
    Am J Health Syst Pharm; 2001 Dec; 58(23):2274-84. PubMed ID: 11763806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological and chemical agents: a brief synopsis.
    Rosenbloom M; Leikin JB; Vogel SN; Chaudry ZA
    Am J Ther; 2002; 9(1):5-14. PubMed ID: 11782813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Training Israeli medical personnel to treat casualties of nuclear, biologic and chemical warfare.
    Rubinshtein R; Robenshtok E; Eisenkraft A; Vidan A; Hourvitz A
    Isr Med Assoc J; 2002 Jul; 4(7):545-8. PubMed ID: 12120469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How would military hospitals cope with a nuclear, biological, or chemical disaster?
    Kenar L; Karayýlanoglu T; Gulec M
    Mil Med; 2004 Oct; 169(10):757-60. PubMed ID: 15532336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anthrax: a disease in waiting?
    Doganay L; Welsby PD
    Postgrad Med J; 2006 Nov; 82(973):754-6. PubMed ID: 17099096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear, biological, and chemical training in the U.S. Army Reserves: mitigating psychological consequences of weapons of mass destruction.
    Knudson GB
    Mil Med; 2001 Dec; 166(12 Suppl):63-5. PubMed ID: 11778441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anthrax: what should the otolaryngologist know?
    Bradley PJ; Ferlito A; Brandwein MS; Benninger MS; Rinaldo A
    Acta Otolaryngol; 2002 Sep; 122(6):580-5. PubMed ID: 12403119
    [No Abstract]   [Full Text] [Related]  

  • 12. [The ABCs on anthrax for health personnel].
    Valdespino-Gómez JL; García-García ML
    Salud Publica Mex; 2001; 43(6):604-13. PubMed ID: 11816237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacteria as agents of biowarfare. How to proceed when the worst is suspected.
    Tjaden JA; Lazarus AA; Martin GJ
    Postgrad Med; 2002 Aug; 112(2):57-60, 63-4, 67-70. PubMed ID: 12198754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [French Armed Forces Medical Corps in case of atomic, biological or chemical warfare].
    GILLYBOEUF G
    Rev Corps Sante Mil; 1956 Mar; 12(1):90-106. PubMed ID: 13323659
    [No Abstract]   [Full Text] [Related]  

  • 15. History of chemical and biological warfare agents.
    Szinicz L
    Toxicology; 2005 Oct; 214(3):167-81. PubMed ID: 16111798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Toxicological effects of weapons of mass destruction and noxious agents in modern warfare and terrorism].
    Vucemilović A
    Arh Hig Rada Toksikol; 2010 Jun; 61(2):247-56. PubMed ID: 20587400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Personal protection during resuscitation of casualties contaminated with chemical or biological warfare agents--a survey of medical first responders.
    Brinker A; Prior K; Schumacher J
    Prehosp Disaster Med; 2009; 24(6):525-8. PubMed ID: 20301071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Operation Desert Shield: medical aspects of weapons of mass destruction.
    Knudson GB
    Mil Med; 1991 Jun; 156(6):267-71. PubMed ID: 1852275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Introduction--What critical care practitioners should know about terrorism agents.
    Hendrickson RG; Hedges JR
    Crit Care Clin; 2005 Oct; 21(4):641-52, v. PubMed ID: 16168306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weapons of mass destruction: Overview of the CBRNEs (Chemical, Biological, Radiological, Nuclear, and Explosives).
    Prockop LD
    J Neurol Sci; 2006 Nov; 249(1):50-4. PubMed ID: 16920155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.